Bone Fracture and Fluoride from FAN
“One cannot help but be alarmed by the negative effects of fluoride on bone strength consistently demonstrated in animal models.” - Dr. Charles Turner, Indiana University.Bone Fracture
No one disputes that high doses of
fluoride wreak havoc on bone tissue. Millions of people throughout the
world, for example, currently suffer a debilitating bone disease called skeletal fluorosis,
which is caused by fluoride. For many years, however, fluoride
advocates believed that fluoride could also benefit bone due to its
ability, under certain circumstances, to increase bone mass. Attempts to
use fluoride as an experimental treatment for osteoporosis, however,
resulted in more
fractures, not less.
More recently, studies of human populations have reported increased fracture rates in communities with 4 mg/L fluoride in the water, and animal studies have consistently found reductions in bone strength from fluoride exposures. Although an increased fracture risk has not been consistently demonstrated at the fluoride levels (0.7-1.2 mg/L) added to water in fluoridation programs, the current weight of clinical, animal, and epidemiological evidence suggests that some individuals in fluoridated communities — particularly those with kidney disease — will suffer fragile bones as a result of their overall fluoride intake, including from fluoridated drinking water.
To determine this, investigators began comparing the bone density and bone fracture rates of communities with varying levels of fluoride in the water. Two consistent findings from these studies emerged: fluoride levels in drinking water (4 mg/L) that are still considered “safe” by the EPA reduce the density of cortical bone and increase the bone fracture rate in a population. Based in part on this research, the U.S. National Research Council (NRC) called on EPA to reduce the allowable levels of fluoride in water. EPA has yet to do so.
As this figure shows, the risk of hip fracture in these populations more than doubled at fluoride levels between 1 and 2.2 ppm. Although this increase was not statistically significant, it suggests the existence of a very narrow margin of safety between the level of fluoride added to water for the prevention of tooth decay and the level of fluoride that weakens bone.
The lack of a safety margin is amplified when considering the relatively low doses of fluoride that the populations in this study were ingesting. These doses are displayed in the following figure:
As can be seen, the risk of hip fracture was distinctly elevated in populations with an average dose of just 6 to 8 mg per day. To put this in perspective, the Department of Health and Human Services has estimated that adults living in fluoridated communities in the U.S. generally ingest between 1.6 and 6.6 mg of fluoride per day. (DHHS 1991). This dose range overlaps the doses associated with hip fracture risk.
fractures, not less.
More recently, studies of human populations have reported increased fracture rates in communities with 4 mg/L fluoride in the water, and animal studies have consistently found reductions in bone strength from fluoride exposures. Although an increased fracture risk has not been consistently demonstrated at the fluoride levels (0.7-1.2 mg/L) added to water in fluoridation programs, the current weight of clinical, animal, and epidemiological evidence suggests that some individuals in fluoridated communities — particularly those with kidney disease — will suffer fragile bones as a result of their overall fluoride intake, including from fluoridated drinking water.
Clinical Trials: High-Dose Fluoride Increases Fracture Rates
For many years, however, fluoride advocates believed that fluoride, under controlled conditions, could benefit bone due to its ability to increase bone mass. In the 1960s, scientists began using fluoride as an experimental drug for the treatment of osteoporosis. Instead of reducing the number of fractures, however, numerous clinical trials reported that the fluoride treatment increased the rate of fractures (particularly hip fractures) and caused a number of other side effects, including gastric distress and joint pain. Based on these results, the FDA rejected the use of fluoride as a medical treatment for treating osteoporosis.Animal & In Vitro Studies: Fluoride Exposure Weakens Bone
Consistent with the clinical trials, numerous animal and in vitro studies have reported that bone strength declines with increased fluoride exposure. As noted in the Journal of Bone and Mineral Research,
“[O]ne cannot help but be alarmed by the negative
effects of fluoride on bone strength consistently demonstrated in animal
models.” (Turner 1995)
Epidemiological Studies:
Fluoride at 4 mg/L Increases Fracture Risk
Following the disastrous results of the experimental trials, researchers began investigating whether current fluoride exposures in the population could pose a similar risk. Although the clinical trials had used high doses of fluoride (20 to 34 mg per day), the trials only lasted for short periods of time (6 months to 4 years). It stands to reason, therefore, that people exposed to lower levels of fluoride for much longer periods of time could be at risk as well.To determine this, investigators began comparing the bone density and bone fracture rates of communities with varying levels of fluoride in the water. Two consistent findings from these studies emerged: fluoride levels in drinking water (4 mg/L) that are still considered “safe” by the EPA reduce the density of cortical bone and increase the bone fracture rate in a population. Based in part on this research, the U.S. National Research Council (NRC) called on EPA to reduce the allowable levels of fluoride in water. EPA has yet to do so.
Fluoride at 1 mg/l: Mixed Evidence of Fracture Risk
A number of studies have sought to determine whether fluoridated drinking water (1 mg/L) also increases the risk of bone fracture. The results of these studies have been mixed, with some studies finding increases in bone fracture, other studies finding no effect, and others finding reductions in fracture risk. As noted by scientists on both sides of the fluoride debate, however, the usefulness of these studies is limited. Most of the studies, for example, only examined older populations that had no exposure to fluoridated water during their childhood (the period of life with the highest rate of fluoride accumulation in bone). Most of the studies, in fact, involved adult populations with less than 20 years of exposure to fluoridated water. The available epidemiological studies on fluoridation and bone fracture provide few definitive answers about the impact of lifetime exposures to artificially fluoridated water.Water Fluoridation: A Very Narrow Margin of Safety
In the NRC’s 2006 review, it noted that there is “suggestive” evidence that the risk of bone fracture increases as the fluoride levels increase from 1 to 4 mg/L. The following figure comes from one of the studies that the NRC cited as providing evidence of a fracture risk below 4 mg/L:As this figure shows, the risk of hip fracture in these populations more than doubled at fluoride levels between 1 and 2.2 ppm. Although this increase was not statistically significant, it suggests the existence of a very narrow margin of safety between the level of fluoride added to water for the prevention of tooth decay and the level of fluoride that weakens bone.
The lack of a safety margin is amplified when considering the relatively low doses of fluoride that the populations in this study were ingesting. These doses are displayed in the following figure:
As can be seen, the risk of hip fracture was distinctly elevated in populations with an average dose of just 6 to 8 mg per day. To put this in perspective, the Department of Health and Human Services has estimated that adults living in fluoridated communities in the U.S. generally ingest between 1.6 and 6.6 mg of fluoride per day. (DHHS 1991). This dose range overlaps the doses associated with hip fracture risk.
A Clear Risk for Kidney Patients
A narrow margin of safety is especially problematic when considering that some subsets of the population, particularly those with advanced kidney disease, have a heightened vulnerability to fluoride. Because people with kidney disease have an impaired ability to excrete fluoride, they accumulate higher levels of fluoride in their bone than healthy individuals. Because of this, kidney patients can be harmed at doses well below those that cause harm in others. Recent research, for example, has found that dialysis patients in fluoridated areas (Ng 2004) accumulate levels of fluoride in their bone that can worsen, if not cause, osteomalacia — a bone-softening disease that causes bones to fracture.-
-
Recent Study on Fluoride & Elk Makes Headlines
As some of you may know, a recent study on fluoride and elk has been attracting quite a bit of media attention recently. The study, published in the journal Ecosystems by scientists at Montana State University, looked at the effects of excess fluoride on the lifespan of elk in Yellowstone National Park.
-
Latest Submission to NRC Panel on Fluoride/Bone
Based on the following data, it is clear that the current MCL can not be relied on to protect against fluoride-induced bone damage, including: reduced bone strength, reduced bone density, increased mineralization defects, exacerbation of bone disease in people with kidney disease, and skeletal fluorosis of varying severity.
-
Study finds link between tea, fluoride, and weak bones
The authors identified 5 patients in their practice who developed skeletal fluorosis as a consequence of drinking tea (primarily darjeeling tea) over a course of 10 to 25 years. The skeletal fluorosis in these patients was the osteomalacic variety of the disease, in which the bones become softened and weak. As a result of the “fluoride-related osteomalacia”, the patients suffered “spontaneous bone fractures” where their bones fractured without external trauma.
Related Articles:
-
-
-
Similarities between Skeletal Fluorosis and Renal Osteodystrophy
It is quite possible, and indeed likely, that some kidney patients diagnosed with renal osteodystrophy are either suffering from skeletal fluorosis or their condition is being complicated/exacerbated by fluoride exposure.
-
Clinical Trials: Fluoride Treatment & Bone Fracture in Osteoporosis Patients
Due to its ability to increase bone mass, fluoride has been used as an experimental treatment for osteoporosis. The results, however, have generally been disastrous. Rather than prevent bone fractures in osteoporosis patients, fluoride therapy (at doses of 20-34 mg/day) was repeatedly found to increase fracture rates. One of the most
-
Fluoride & Spontaneous Hip Fractures in Osteoporosis Patients
Due to its ability to increase vertebral bone mass, fluoride has been used as an experimental treatment for osteoporosis (doses > 20 mg/day). Fluoride treatment, however, proved far more harmful than beneficial. Not only was fluoride therapy shown to increase fracture rates among the treated patients, it was also found to
Related Studies:
-
No comments:
Post a Comment